Medicare AdvantageCoverageLow impact
MA08.133d, Evinacumab-dgnb (Evkeeza®)
Independence Blue Cross·Cardiology, Endocrinology, Internal Medicine +1 more·Pharmacy
Effective date
Dec 10, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA08.133d for Evinacumab-dgnb (Evkeeza®) has been reissued effective December 10, 2025. This is a pharmacy policy update that may affect coverage or billing requirements for this cholesterol-lowering medication.
Action Required
By December 10, 2025: Review the full policy details at the provided URL to understand specific coverage criteria for Evinacumab-dgnb (Evkeeza®). Billing team should verify current prior authorization requirements and update any relevant billing procedures for Medicare Advantage patients requiring this medication.